Determination of process-related impurities in N-acetylglucosamine prepared by chemical and enzymatic methods: structural elucidation and quantification
- 300 Downloads
β-N-acetylglucosamine (β-AG) is a monosaccharide distributed widely in living organisms with various pivotal roles. The presence of particulates and impurities can affect the safety and efficacy of a product for its intended duration of use. Thus, the current study was carried out to identify and quantify the potentially-harmful process related impurities; namely α-N,6-diacetylglucosamine (α-DAG) and α-N-acetylglucosamine (α-AG), derived from the chemical and enzymatic synthesis of β-AG. The impurities were characterized using a high resolution mass spectrometry, a nuclear magnetic resonance spectroscopy, and liquid chromatography-tandem mass spectrometry (LC/MS/MS). The developed method showed a good linearity (R 2 ≥ 0.998), satisfactory precision (≤6.1 % relative standard deviation), intra- and inter-day accuracy (88.20–97.50 %), extraction recovery (89.30–110.50 %), matrix effect (89.70–105.20 %), and stability (92.70–101.60 %). The method was successfully applied to determine the level of α-DAG that was 3.04 and 0.07 % of the total β-AG, following chemical and enzymatic methods, respectively. It can be concluded that the enzymatic rather than the chemical method is more efficient for the synthesis of β-AG. Characterization of impurities heeds the signal for acquiring and evaluating data that establishes biological safety.
Keywordsβ-N-acetylglucosamine Process-related impurity Tandem mass spectrometry Chitin Nuclear magnetic resonance
This work was supported by Amicogen, INC., Jinju, Republic of Korea.
Compliance with ethical standards
Conflict of interest
The authors have declared no conflict of interest.
- Haynes CA, Aloise P, Creagh AL (1999) Process for producing N-acetyl-d-glycosamine. U.S. Patent 5,998,173. https://www.google.com/patents/US5998173?dq=inassignee:%22The+University+Of+Bristish+Columbia%22&hl=en&sa=X&ved=0ahUKEwioh8X2p9_JAhWj4KYKHSYZDm8Q6AEIJDAB
- Jollès P, Muzzarelli RAA (eds) (1999) Chitin and chitinases. Birkhauser Verlag publishers, BaselGoogle Scholar
- Sashiwa H, Fujishima S, Yamano N, Kawasaki N, Nakayama A, Muraki E, Sukwattanasinitt M, Pichyangkura R, Aiba S (2003) Enzymatic production of N-acetyl-d-glucosamine from chitin. Degradation study of N-acetylchitooligosaccharide and the effect of mixing of crude enzymes. Carbohydr Polym 51:391–395CrossRefGoogle Scholar
- Sato M, Ishikawa O, Yokoyama Y, Kondo A, Miyachi Y (1996) Focal dermal hypoplasia (Goltz syndrome): a decreased accumulation of hyaluronic acid in three-dimensional culture. Acta Dermato-Venereol 76:365–367Google Scholar
- Shibata K, Tsubouchi R (2008) Clinical effects of N-acetylglucosamine supplementation on dry skin. Aesthet Dermatol 18:91–99Google Scholar
- Shin YC, Jun YJ, Yoon YC, Kim YS (2006) Chitinase-producing trichoderma viride A G C C-M41strain, chitinases purified therefrom and a method for producing N-acetylglucosamine using the chitinases. Republic of Korea. Patent 10-2006-0070224. http://kpat.kipris.or.kr/kpat/biblioa.do?method=biblioFrame
- U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry, bioanalytical method validation; FDA (2001)Google Scholar
- Zhan WS (2007) Process for preparing refined N-acetyl-d-aminoglucose. PAT—CN1907993Google Scholar